Quoin Pharmaceuticals (QNRX) said Friday it has priced a public offering of 15.1 million American Depositary Shares, along with Series F and Series G warrants to purchase an equal number of ADSs, at $0.45 per ADS for a total of $6.8 million in gross proceeds.
One ADS represents one ordinary share of the company.
The funds will be used for general corporate purposes, including research and development, Quoin Pharmaceuticals said.
The offering is expected to close by Monday.
Quoin Pharmaceuticals shares fell nearly 6% in recent trading.
Price: 0.61, Change: -0.04, Percent Change: -5.69
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments